• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名银屑病患者在使用依那西普治疗期间发生继发性全身性皮肤粘蛋白沉积症。

Secondary Generalized Cutaneous Mucinosis Developed During Etanercept Treatment in a Patient with Psoriasis.

作者信息

Zhou Xin, Mubanga David, Chen Zhuo, Bi Xinling

机构信息

Department of Dermatology, Changhai Hospital, Naval Medical University, Shanghai, 200433, People's Republic of China.

Department of Dermatology, Maina Soko Military Hospital, Lusaka, Zambia.

出版信息

Clin Cosmet Investig Dermatol. 2022 May 31;15:987-992. doi: 10.2147/CCID.S368390. eCollection 2022.

DOI:10.2147/CCID.S368390
PMID:35669090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9166950/
Abstract

Cutaneous mucinosis is a rare disease that manifests as an excessive accumulation of mucin in the skin that forms waxy papules or plaques. We report a case of a 44-year-old male psoriatic patient who developed generalized cutaneous mucinosis after 11 months of biological treatment. The patient had a history of psoriasis for 20 years and had been treated with narrow-band UVB phototherapy, methotrexate, or acitretin intermittently. He was started on etanercept after he was diagnosed with psoriatic arthritis, and 11 months later, he complained of swelling in his extremities and myxoid cysts on his fingers. Etanercept was then discontinued due to loss of efficacy and widespread skin lesions. However, the lesions subsided spontaneously after 6 months without specific systemic treatment.

摘要

皮肤黏蛋白沉积症是一种罕见疾病,表现为皮肤中黏蛋白过度积聚,形成蜡样丘疹或斑块。我们报告一例44岁男性银屑病患者,在生物治疗11个月后发生泛发性皮肤黏蛋白沉积症。该患者有20年银屑病病史,曾间断接受窄谱中波紫外线光疗、甲氨蝶呤或阿维A治疗。他在被诊断为银屑病关节炎后开始使用依那西普,11个月后,他抱怨四肢肿胀和手指出现黏液样囊肿。由于疗效丧失和广泛的皮肤病变,依那西普随后停药。然而,未经特殊系统治疗,6个月后病变自行消退。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/9166950/60baa883efd1/CCID-15-987-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/9166950/50aba3ce1363/CCID-15-987-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/9166950/698cbcc5f5d0/CCID-15-987-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/9166950/47e1c3914097/CCID-15-987-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/9166950/60baa883efd1/CCID-15-987-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/9166950/50aba3ce1363/CCID-15-987-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/9166950/698cbcc5f5d0/CCID-15-987-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/9166950/47e1c3914097/CCID-15-987-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/38a6/9166950/60baa883efd1/CCID-15-987-g0004.jpg

相似文献

1
Secondary Generalized Cutaneous Mucinosis Developed During Etanercept Treatment in a Patient with Psoriasis.一名银屑病患者在使用依那西普治疗期间发生继发性全身性皮肤粘蛋白沉积症。
Clin Cosmet Investig Dermatol. 2022 May 31;15:987-992. doi: 10.2147/CCID.S368390. eCollection 2022.
2
Can biologic treatment induce cutaneous focal mucinosis?生物治疗能诱发皮肤局限性粘蛋白病吗?
Postepy Dermatol Alergol. 2014 Dec;31(6):413-6. doi: 10.5114/pdia.2014.40944. Epub 2014 Dec 22.
3
Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis.依那西普治疗人类免疫缺陷病毒相关的银屑病关节炎。
Mayo Clin Proc. 2000 Oct;75(10):1093-8. doi: 10.4065/75.10.1093.
4
[Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].[寻常型银屑病的窄谱中波紫外线治疗:法国光皮肤病学会的实用指南与建议]
Ann Dermatol Venereol. 2010 Jan;137(1):21-31. doi: 10.1016/j.annder.2009.12.004. Epub 2009 Dec 29.
5
Laser Doppler perfusion imaging (LDPI) and transepidermal water loss (TEWL) values in psoriatic lesions treated with narrow band UVB phototherapy. Dermal vascularity may be useful indicator of psoriatic activity.窄带紫外线B光疗治疗银屑病皮损的激光多普勒血流成像(LDPI)和经表皮水分流失(TEWL)值。皮肤血管状态可能是银屑病活动的有用指标。
Ann Acad Med Singap. 2004 Jan;33(1):75-9.
6
The Paradoxical Induction of Crohn’s Disease Following Treatment of Psoriatic Arthritis With Etanercept.用依那西普治疗银屑病关节炎后克罗恩病的矛盾性诱发
J Drugs Dermatol. 2019 Aug 1;18(8):832-834.
7
Congenital cutaneous mucinosis with spontaneous regression: an atypical cutaneous mucinosis of infancy?先天性皮肤黏液病伴自发性消退:一种非典型的婴儿期皮肤黏液病?
Clin Exp Dermatol. 2009 Oct;34(7):804-7. doi: 10.1111/j.1365-2230.2008.03000.x. Epub 2008 Dec 9.
8
Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.依那西普联合窄谱中波紫外线光疗治疗银屑病在 6 周时比依那西普单药治疗更有效。
Br J Dermatol. 2011 Jun;164(6):1383-6. doi: 10.1111/j.1365-2133.2011.10358.x.
9
A case report of atypical nodular cutaneous lupus mucinosis.非典型结节性皮肤狼疮黏蛋白病一例报告
Medicine (Baltimore). 2017 Dec;96(49):e8391. doi: 10.1097/MD.0000000000008391.
10
Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.生物制剂联合常规系统药物或光疗治疗银屑病:来自 PSONET 登记处的真实数据。
J Eur Acad Dermatol Venereol. 2018 Feb;32(2):245-253. doi: 10.1111/jdv.14583. Epub 2017 Oct 17.

引用本文的文献

1
Deciphering Deleterious nsSNPs in MUC16's SEA Domain: Structural and Functional Implications in Cancer Metastasis via Computational Analysis.通过计算分析破译MUC16 SEA结构域中的有害错义单核苷酸多态性:对癌症转移的结构和功能影响
J Cell Mol Med. 2025 Jun;29(11):e70633. doi: 10.1111/jcmm.70633.
2
Solitary acral persistent papular mucinosis nodule: A case report and summary of eight Korean cases.孤立性肢端持续性丘疹性黏蛋白沉积症结节:一例报告及八例韩国病例总结
World J Clin Cases. 2023 May 6;11(13):3086-3091. doi: 10.12998/wjcc.v11.i13.3086.

本文引用的文献

1
Cutaneous mucinosis in a patient taking ustekinumab for palmoplantar psoriasis.一名正在服用乌司奴单抗治疗掌跖银屑病的患者出现皮肤黏蛋白沉积症。
Dermatol Online J. 2017 Mar 15;23(3):13030/qt2s2128vw.
2
Can biologic treatment induce cutaneous focal mucinosis?生物治疗能诱发皮肤局限性粘蛋白病吗?
Postepy Dermatol Alergol. 2014 Dec;31(6):413-6. doi: 10.5114/pdia.2014.40944. Epub 2014 Dec 22.
3
[Multiple lesions of focal cutaneous mucinosis: a side-effect of anti-TNF alpha therapy?].
Ann Dermatol Venereol. 2010 Feb;137(2):140-2. doi: 10.1016/j.annder.2010.01.001. Epub 2010 Jan 29.
4
Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review.抗肿瘤坏死因子生物疗法的皮肤副作用:一项临床综述。
J Am Acad Dermatol. 2009 Sep;61(3):486-504. doi: 10.1016/j.jaad.2008.10.060. Epub 2009 Jul 22.
5
Generalized mucinosis in a patient with erythroderma.红皮病患者的泛发性粘蛋白沉积症
Dermatology. 2006;212(4):366-9. doi: 10.1159/000092288.
6
Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.浆细胞样前体树突状细胞通过产生α-干扰素引发银屑病。
J Exp Med. 2005 Jul 4;202(1):135-43. doi: 10.1084/jem.20050500.
7
Cutaneous mucinosis and skin necrosis complicates interferon alfacon-1 (consensus interferon) treatment of chronic hepatitis C.
Eur J Med Res. 2005 Feb 28;10(2):63-7.
8
Etanercept in psoriasis.
Expert Opin Pharmacother. 2004 Oct;5(10):2139-46. doi: 10.1517/14656566.5.10.2139.
9
Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders.肿瘤坏死因子(TNF)通路的抑制:在治疗抵抗性慢性炎症性疾病中使用英夫利昔单抗和依那西普作为诱导缓解药物。
Swiss Med Wkly. 2002 Jul 27;132(29-30):414-22. doi: 10.4414/smw.2002.10031.
10
Diffuse cutaneous mucinoses.
Dermatol Clin. 2002 Jul;20(3):493-501. doi: 10.1016/s0733-8635(02)00017-7.